Your browser doesn't support javascript.
loading
Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of Medical Oncology).
Inal, Ali; Kos, F Tuba; Algin, Efnan; Yildiz, Ramazan; Berk, Veli; Unek, Ilkay T; Colak, Dilsen; Dane, Faysal; Geredeli, Caglayan; Isikdogan, Abdurrahman.
Affiliation
  • Inal A; Department of Medical Oncology, School of Medicine, Dicle University, Diyarbakir, Turkey.
  • Kos FT; Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey.
  • Algin E; Department of Medical Oncology, Gazi University, Ankara, Turkey.
  • Yildiz R; Dr. Lütfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey.
  • Berk V; Department of Medical Oncology, Erciyes University, Kayseri, Turkey.
  • Unek IT; Department of Medical Oncology, Dokuz Eylül University, Izmir, Turkey.
  • Colak D; Yildirim Beyazit Education and Research Hospital, Ankara, Turkey.
  • Dane F; Marmara University School of Medicine, Division of Medical Oncology, Istanbul, Turkey.
  • Geredeli C; Secuk University, Meram Medical Faculty, Konya, Turkey.
  • Isikdogan A; Department of Medical Oncology, Dicle University, Diyarbakir, Turkey.
Contemp Oncol (Pozn) ; 19(2): 125-9, 2015.
Article in En | MEDLINE | ID: mdl-26034390
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Contemp Oncol (Pozn) Year: 2015 Type: Article Affiliation country: Turkey
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Contemp Oncol (Pozn) Year: 2015 Type: Article Affiliation country: Turkey